Head-to-head · Value Score
ShedRx vs Rebody Health
Two GLP-1 deals, scored on the same six factors. ShedRx lands a Value Score of 84, Rebody Health a 74. Here's who gives you the honest lower price — and where each one bites back.
ShedRx
#23 · Grade B+ · Good Value
Est. first month
$199/mo
Save ~85% vs brand-nameRebody Health
#149 · Grade C+ · Watch List
Est. first month
From $200/mo (starting dose, compounded)
Save ~85% vs brand-nameThe verdict
ShedRx takes it on Value Score, 84 to 74 — an est. $199/mo first month, though we flag its pricing to watch. Rebody Health isn't out of it: Shoppers who want transparent, dose-based GLP-1 pricing with oral, injectable, or brand-name options.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | ShedRx | Rebody Health |
|---|---|---|
| Value Score | 84 (B+) | 74 (C+) |
| Est. first month | $199/mo | From $200/mo (starting dose, compounded) |
| Save vs brand-name | ~85% | ~85% |
| Semaglutide | $199/mo | From $200/mo (starting dose, compounded) |
| Tirzepatide | $299/mo | From $250/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Watch | Watch |
| Coverage | All 50 states | 47 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
ShedRx
Good headline prices and four routes to a GLP-1 — but the cheapest numbers it advertises need a year-long commitment.
Why it's a deal
- Four routes — injection, liquid drops, lozenges and a daily oral pill — plus brand Zepbound and Wegovy
- $299 month-to-month tirzepatide is still competitive against flat-fee rivals
- Available in all 50 states, with health coaching included
The fine print
- The advertised "as low as $239" needs a twelve-month commitment — month-to-month is $299
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- The dispensing compounding pharmacy is not publicly named
Rebody Health
Rebody Health (rebodyhealth.com), operated by Compound Technologies Inc., is a transparent-pricing GLP-1 and wellness telehealth service that publishes prices up front.
Why it's a deal
- Publishes transparent, dose-based pricing up front on a public pricing page, so you can see costs without signing up
- Offers compounded semaglutide and tirzepatide as both weekly injections and daily oral 'melt' tablets
- Also carries brand-name Wegovy and Zepbound for patients who want FDA-approved products
- Clear plan-term vs dose-tier structure; the refill price is shown before each shipment, plus $50 off the first month
- Names its operating company (Compound Technologies Inc.) and references LegitScript approval
The fine print
- Individual compounding pharmacies are not named on the marketing site
- Not available in Massachusetts, Rhode Island, or Vermont
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
- Dose-scaled pricing means the monthly cost can rise as your prescribed dose increases
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores ShedRx is ranked on the ShedRx alternatives ranking, and the same list for the other side is on alternatives to Rebody Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.